Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study for Prostate Cancer, Randomizing Between Two Radiation Dose Levels (68 Gy vs. 78 Gy) and Utilizing Three Dimensional Conformal Radiotherapy

NCT00692107 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT00692107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00692107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study for Prostate Cancer, Randomizing Between Two Radiation Dose Levels (68 Gy vs. 78 Gy) and Utilizing Three Dimensional Conformal Radiotherapy
Lead sponsor
The Netherlands Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1997
Completion date
December 31, 2007
Enrollment
669 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms